Cholesterol-lowering drug Lipitor reduces mortality in study

08/29/2011 | CNN/The Chart blog

A follow-up study in the European Heart Journal found that patients taking Pfizer's cholesterol-lowering statin Lipitor had a 14% lower death rate compared with placebo users. The finding was attributed mainly to a significant reduction in mortality from respiratory and infectious diseases. A clinical trial of Lipitor ended in 2003 after the statin demonstrated effectiveness in preventing stroke and heart attack.

View Full Article in:

CNN/The Chart blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD